Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development

Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development

Patients with cirrhosis are at risk of hepatocellular carcinoma (HCC) development and, according to current guidelines, should undergo surveillance by ultrasound at six month intervals. Due to the known limitations of surveillance strategies based on ultrasonography, the use of tumor biomarkers, alt...

Full description

Bibliographic Details
Main Authors: Gian Paolo Caviglia, Maria Lorena Abate, Giulia Troshina, Patrizia Carucci, Emanuela Rolle, Alessandra Risso, Michela Emma Burlone, Alice Albè, Martina Crevola, Emma Clara Musso, Chiara Rosso, Angelo Armandi, Antonella Olivero, Rosalba Minisini, Giorgio Maria Saracco, Elisabetta Bugianesi, Mario Pirisi, Alessia Ciancio, Silvia Gaia
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Biology
Subjects:
biomarkers
HCC
protein induced by vitamin K absence or antagonist II
Online Access:https://www.mdpi.com/2079-7737/12/1/94

Internet

https://www.mdpi.com/2079-7737/12/1/94

Similar Items